Photo from Shankar Siva/X
Oct 1, 2024, 15:49
Shankar Siva: QoL outcomes in the adaptive radiotherapy SPRINT PET trial
Shankar Siva, Radiation Oncologist at the Peter MacCallum Cancer Centre, shared on X:
“ASTRO24 – Dr. Ohri discussed quality of life outcomes in the adaptive radiotherapy SPRINT PET ‘chemotherapy-free’ lung cancer trial.
76% PFS already reported at 1-year, and now quality of outcomes with RT and pembrolizumab
de-intensification appears favorable!”
Source: Shankar Siva/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 11, 2025, 01:37
Mar 10, 2025, 16:42
Mar 10, 2025, 16:13
Mar 10, 2025, 16:07
Mar 10, 2025, 15:36
Mar 10, 2025, 15:17